je.st
news
Ariad shares fall as it cuts revenue guidance
2015-12-12 15:42:31| Biotech - Topix.net
Shares of Ariad Pharmaceuticals fell Friday after it cut revenue guidance as it continues to negotiate with French regulators over the price of its leukemia treatment, Iclusig. The Cambridge, Massachusetts-based developer of cancer treatments said that it previously expected to reach an agreement by the end of the year, but it now expects negotiations to continue into 2016.
Tags: fall
revenue
shares
guidance
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||